Khoramnia, Ramin http://orcid.org/0000-0002-6237-7773
Nguyen, Quan Dong http://orcid.org/0000-0002-6024-8441
Kertes, Peter J. http://orcid.org/0000-0002-0348-5096
Sararols Ramsay, Laura
Vujosevic, Stela http://orcid.org/0000-0001-6773-9967
Anderesi, Majid
Igwe, Franklin
Eter, Nicole
Funding for this research was provided by:
Novartis
Article History
Received: 23 January 2023
Revised: 16 May 2023
Accepted: 13 June 2023
First Online: 21 July 2023
Competing interests
: RK reports grants from Chengdu Kanghong; grants, personal fees, and nonfinancial support from Alimera, Bayer, Novartis, Roche, and Zeiss; and personal fees and nonfinancial support from Allergan, Apellis, and Heidelberg Engineering. QDN reports consulting fees from Boehringer Ingelheim, Genentech, Kriya, and Regeneron. PJK reports research support from Bayer, Novartis, RenegxBio, and Roche; honoraria for advisory boards from Apellis, Bayer, Boehringer Ingelheim, Biogen, Novartis, Roche, and Viatris; lecture fees from Bayer, Pfizer, and Zeiss; support for meetings/travel from Apellis, Bayer, and Roche; advisory board membership for Apellis and Novelty Nobility; equity ownership in ArcticDx; and medical writiting support from Novartis. LSR reports payment/honoraria from Bayer and Novartis; support for meetings/travel from Bayer, Novartis, and Roche; and participation in advisory boards for Bayer, Novartis, and Roche. SV reports consulting fees from Abbvie, Alimera, Bayer, Boehringer Ingelheim, Novartis, Roche, and Zeiss; payments/honoraria from Abbvie, Alimera, Apellis, Bayer, Novartis, Roche, and Zeiss; and participation in advisory boards for Abbvie, Alimera, Apellis, Bayer, Boehringer Ingelheim, Novartis, and Roche. MA is an employee of OcuTerra Therapeutics and was an employee of Novartis at the time the manuscript was initiated. FI is an employee and shareholder of Novartis Pharma AG. NE reports grants to her department from Bayer and Novartis; consulting fees from Alcon, Allergan, Apellis, Bayer, Novartis, and Roche; payments/honoraria from Allergan, Apellis, Bayer, Novartis, and Roche; and support for meetings/travel from Roche.